Allegro Ophthalmics

Allegro Ophthalmics

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ AAO 2019Подробнее

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ AAO 2019

Allegro ventures into the anterior segmentПодробнее

Allegro ventures into the anterior segment

Treating Age-Related Macular Degeneration Interview with Allegro Ophthalmics, Vicken Karageozian, MDПодробнее

Treating Age-Related Macular Degeneration Interview with Allegro Ophthalmics, Vicken Karageozian, MD

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ ASRS 2019Подробнее

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ ASRS 2019

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ ASCRS 2019Подробнее

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ ASCRS 2019

Ophthalmology Innovator Stories: What Is Allegro Ophthalmics?Подробнее

Ophthalmology Innovator Stories: What Is Allegro Ophthalmics?

Eric D. Donnenfeld, MD, FAAO - ASCRS 2019Подробнее

Eric D. Donnenfeld, MD, FAAO - ASCRS 2019

Allegro Ophthalmics Preps for Phase III of RisuteganibПодробнее

Allegro Ophthalmics Preps for Phase III of Risuteganib

Allegro’s Luminate Achieves Primary Endpoint in DME Trial (OIS@AAO 2016)Подробнее

Allegro’s Luminate Achieves Primary Endpoint in DME Trial (OIS@AAO 2016)

Allegro Plans for Phase III of LuminateПодробнее

Allegro Plans for Phase III of Luminate

Allegro’s Karageozian (OIS@AAO 2016)Подробнее

Allegro’s Karageozian (OIS@AAO 2016)

Allegro Ophthalmics - OIS@AAO 2015Подробнее

Allegro Ophthalmics - OIS@AAO 2015

Allegro Ophthalmics Reports Phase II Data for LuminateПодробнее

Allegro Ophthalmics Reports Phase II Data for Luminate

Allegro Ophthalmics: First-in-Class Anti-Integrin Agent (OIS@ASRS 2016)Подробнее

Allegro Ophthalmics: First-in-Class Anti-Integrin Agent (OIS@ASRS 2016)